Zdrowie i gospodarka · 28/12/2023
FDA Releases Revised Draft Guidance for Topical Ophthalmic Drug Products
The Food and Drug Administration (FDA) has released a revised draft guidance for industry on quality considerations for topical ophthalmic drug products, covering aspects such as microbiology, particulate matter, and stability studies.
Source: Federal Register — Food and Drug AdministrationOpen original release →